期刊文献+

赤芝中脂溶性化合物的体外抗肿瘤活性 被引量:21

Liposoluble Compounds Isolated from Ganoderma lucidum and Their Cytotoxic Activity against Tumor Cells in vitro
下载PDF
导出
摘要 从赤芝中分离获得3个化合物:灵芝萜烯酮醇(Ⅰ)、麦角甾-7,22-二烯-3β-醇(Ⅱ)、过氧化麦角甾醇(Ⅲ)。化疗药物顺氯氨铂(DDP)作为阳性对照,用MTT(microculture tetrazolium)法和形态学方法评定了它们对人肝癌细胞株BEL-7402、人胃癌细胞株MGC-803的增殖抑制作用。Ⅰ、Ⅱ、Ⅲ、DDP对BEL-7402的半数抑制浓度IC50值分别为:20.15、5.05、24.35、7.67μmol/L;对MGC-803的IC50值分别为:6.32、10.09、9.88、3.52μmol/L。Ⅰ和Ⅱ分别与DDP以质量比1∶1混合处理BEL-7402细胞有正协同作用,效果明显优于单独使用DDP。化合物Ⅰ、Ⅱ、Ⅲ对HMEC人微血管内皮细胞的毒性很小,质量浓度6.25 mg/L的Ⅰ甚至能促其增殖,增长率为0.93%,Ⅱ、Ⅲ的抑制率仅为21.14%和2.86%。Ⅰ、Ⅱ、Ⅲ是极具潜力的抗肿瘤药物。 Three compounds from Ganoderma lucidum were obtained and identified as ganodermenonol ( Ⅰ ), ( 22E, 24R ) -ergosta-7,22-dien-3β-ol ( Ⅱ ) and ergosterol peroxide ( Ⅲ ). MTT ( microcuhure tetrazolium) assay and morphological method were used to evaluate the inhibitive effect of compounds on the proliferation of human hepatocarcinoma cell line BEL - 7402 and human gastric cancer cell line MGC- 803, in contrast to the positive control of cis-diaminedichloroplatinum (DDP). The IC50 values of Ⅰ , Ⅱ, Ⅲ and DDP towards BEL -7402 cell were 20. 15,5.05,24.35 and 7.67 μmol/L respectively, and those towards MGC -803 cell were 6.32, 10. 09, 9. 88 and 3.52 μmol/L respectively. When combined with DDP, Ⅰ and Ⅱ have synergistic interaction against BEL- 7402 cells. On the other hand, they have but very low toxicity impact on HMEC, no matter used alone or combined with DDP. Compound Ⅰ even increased the proliferation of HMEC cells by 0. 93% at 6.25 mg/L. The inhibitive ratios of Ⅱ and Ⅲ toward HMEC cells were only 21.14 % and 2. 86 %.
作者 陆易 翁新楚
出处 《精细化工》 EI CAS CSCD 北大核心 2007年第8期772-777,共6页 Fine Chemicals
基金 上海市科委资助项目(04DZ19847)~~
关键词 赤芝 灵芝萜烯酮醇 麦角甾-7 22-二烯-3β-醇 过氧化麦角甾醇 MTT法 抗肿瘤 中药现代化 Ganoderma lucidum ganodermenonol ( 22E, 24R ) -ergosta-7,22-dien-3β-ol ergosterol peroxide MTT assay antitumor modernization of Chinese medicine
  • 相关文献

参考文献25

  • 1蔺丽,方能虎,吴旦.灵芝有效成份的研究概况[J].中成药,2002,24(10):793-796. 被引量:46
  • 2钟小清.灵芝研究概况[J].广西中医药,1999,22(6):44-47. 被引量:9
  • 3陈若芸,于德泉.灵芝三萜化学成分研究进展[J].药学学报,1990,25(12):940-953. 被引量:85
  • 4Lin Shwu-Bin,Li Chyi-Hann,Lee Shiuh-Sheng,et al.Triterpene-enriched extracts from Ganoderma lucidum inhibit growth of hepatoma cells via suppressing protein kinase C,activating mitogen-activated protein kinases and G2-phase cell cycle arrest[J].Life Science,2003,72:2381-2391.
  • 5Hassan Hajjaj,Catherine Mace',Matthew Roberts,et al.Effect of 26-Oxygenosterols from Ganoderma lucidum and their activity as cholesterol synthesis inhibitors[J].Appl Environ Microbiol,2005,71(7):3653-3658.
  • 6Munehisa Arisawa,Akio Fujita,Manabu Saga,et al.Three new lanostanoids from Ganoderma lucidum[J].Journal of Natural Products,1986,49(4):621-625.
  • 7Lin,Tome W P,Won S J.A lanostanoid of Formosan Ganoderma lucidum[J].Phytochemistry,1990,29(2):673-675.
  • 8马伟光,李兴从,王德祖,杨崇仁.松橄榄中的麦角甾醇类过氧化物[J].云南植物研究,1994,16(2):196-200. 被引量:49
  • 9Sheu J H,Chang K C,Duh C Y.A cytotoxic 5α,8α-epidioxysterol from a soft oral sinularia species[J].J Nat Prod,2000,63(1):149-151.
  • 10Sliva D.Cellular and physiological effects of Ganoderma lucidum (Reishi)[J].Mini Rev Med Chem,2004,4(8):873-879.

二级参考文献59

共引文献187

同被引文献243

引证文献21

二级引证文献132

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部